Dissolution profiles of formulations containing POVIDONE solid
Effect of Self-Microemulsifying Lipid Formulations on the Dissolution and Compaction Profiles of Tablets Containing Theophylline; A BCS Class I Compound
9
Dissolution characterization of compounded ibuprofen containing tablet formulations for potentially faster pain relief: the effects of disintegrants
6
Dissolution Behavior of Amorphous Solid Dispersions
247
Influence of Different Meltable Binders on the Solid- State Behaviour and Dissolution Profiles of Solid Lipid Extrudates Processed Via Continuous Hot Melt Granulation
27
Investigation of the Dissolution Characteristics of Nifedipine Extended-Release Formulations Using USP Apparatus 2 and a Novel Dissolution Apparatus
7
Biorelevant Dissolution Methods and Their Applications in In Vitro- In Vivo Correlations for Oral Formulations
12
ENHANCEMENT OF DISSOLUTION RATE OF LERCANIDINE BY SOLID DISPERSION TECHNIQUE
8
Preparation of solid dispersions of glibenclamide for in-vitro dissolution enhancement
6
Enhancement of Solubility and Dissolution Rate of Lopinavir by Solid Dispersion Technique.
98
ENHANCEMENT OF SOLUBILITY AND DISSOLUTION CHARACTERISTICS OF FUROSEMIDE BY SOLID DISPERSION TECHNIQUE
24
COMPARATIVE STUDY ON THE DISSOLUTION PROFILES OF COMMERCIAL MODIFIED RELEASE FORMULATIONS OF NIFEDIPINE
16
Advancements in Composite Solid Propellant Testing and Evaluation for Formulations Containing Novel Nano-Additives
169
Assessment of Dissolution Profile of Marketed Aceclofenac Formulations
6
UV-Vis Spectroscopy to Enable Determination of the Dissolution Behavior of Solid Dispersions Containing Curcumin and Piperine
5
Spectroscopic Imaging of the Compaction and Dissolution of Model Pharmaceutical Formulations
274
A Multivariate Test For Similarity of Two Dissolution Profiles
20
A MULTIVARIATE TEST FOR SIMILARITY OF TWO DISSOLUTION PROFILES
14
THE DEVELOPMENT OF DIFFERENT FORMULATIONS CONTAINING 2% CHLORHEXIDINE DIGLUCONATE AND PRELIMINARY EVALUATION OF THE STABILITY OF THE FORMULATIONS
9
Design and in-vitro evaluation of Lisinopril transdermal patches containing Ethylcellusose-povidone as film formers
8
Design and in vitro evaluation of haloperidol transdermal patches containing PVA-Povidone as film formers
10